Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Opioid advocates urge DC to switch to generic naloxone for roughly 20% cost savings
Summary
An Opioid Abatement Advisory Commission member told the Council committee that the District can save about 20% per naloxone unit by purchasing a generic formulation approved with a 36‑month shelf life and redirect savings to other services.
Chad Jackson, chairman of the Opioid Abatement Advisory Commission and a local provider with lived‑experience in recovery, urged the Committee on Health to consider switching the District’s naloxone procurement to a generic formulation that he said would cost approximately $27 per unit instead of the $33 per unit the city currently pays for a branded product.
Jackson said the district has a contract that purchases…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
